BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32394752)

  • 1. Barriers to implementing pharmacoeconomics: interview study.
    Alefan Q; Hamdouni E; Alhamad H; Mukattash T; Rascati K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):93-104. PubMed ID: 32394752
    [No Abstract]   [Full Text] [Related]  

  • 2. Barriers and Facilitators of Pharmacoeconomic Studies: A Review of Evidence from the Middle Eastern Countries.
    Alzarea AI; Khan YH; Alanazi AS; Butt MH; Almalki ZS; AlAhmari AK; Alsahali S; Mallhi TH
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.
    Alsultan MS
    Saudi Pharm J; 2011 Jan; 19(1):51-6. PubMed ID: 23960742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy benefit management: enhancing the applicability of pharmacoeconomics for optimal decision making.
    Mullins CD; Wang J
    Pharmacoeconomics; 2002; 20(1):9-21. PubMed ID: 11817989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of pharmacoeconomics to formulary decision making in managed care organizations.
    Suh DC; Okpara IR; Agnese WB; Toscani M
    Am J Manag Care; 2002 Feb; 8(2):161-9. PubMed ID: 11858228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of pharmacoeconomics in the research and development decision-making process.
    DiMasi JA; Caglarcan E; Wood-Armany M
    Pharmacoeconomics; 2001; 19(7):753-66. PubMed ID: 11548911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomic education in Egyptian schools of pharmacy.
    Soliman AM; Hussein M; Abdulhalim AM
    Am J Pharm Educ; 2013 Apr; 77(3):57. PubMed ID: 23610475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.
    Mashaba TP; Matlala M; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):159-168. PubMed ID: 30407089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Application of Pharmacoeconomic Evaluations in Medicines Management by Hospital Pharmacists in Nigeria: A Cross-Sectional Survey.
    Oamen TE; Osemene KP; Ihekoronye RM
    Hosp Top; 2023; 101(3):165-174. PubMed ID: 34821536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A conceptual framework toward identifying and analyzing challenges to the advancement of pharmacy.
    Bader LR; McGrath S; Rouse MJ; Anderson C
    Res Social Adm Pharm; 2017; 13(2):321-331. PubMed ID: 27117185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacoeconomic picture in Saudi Arabia.
    Alkhenizan A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?
    Aburuz S; Al-Ghazawi M; Snyder A
    Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacoeconomics].
    Shiragami M
    Yakugaku Zasshi; 2003 Mar; 123(3):133-42. PubMed ID: 12693013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics and clinical practice guidelines. A survey of attitudes in Swedish formulary committees.
    Anell A; Svarvar P
    Pharmacoeconomics; 2000 Feb; 17(2):175-85. PubMed ID: 10947340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do economic evaluations have a role in decision-making in Medicine Management Committees? A qualitative study.
    Chen LC; Ashcroft DM; Elliott RA
    Pharm World Sci; 2007 Dec; 29(6):661-70. PubMed ID: 17566869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomics and immunotherapy.
    Berto P
    Eur Ann Allergy Clin Immunol; 2007; 39 Spec No():12-6. PubMed ID: 18924461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Awareness, knowledge, and attitudes of health professions students toward health economics and pharmacoeconomics education in Jordan.
    Hammad EA; Mousa R; Hammad AA; Al-Qudah M
    Curr Pharm Teach Learn; 2020 Sep; 12(9):1072-1080. PubMed ID: 32624136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective.
    Thwaites R; Townsend RJ
    Pharmacoeconomics; 1998 Feb; 13(2):175-80. PubMed ID: 10178645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.